Failure of Delta(9)-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys. 1994

R.S. Mansbach, and K.L. Nicholson, and B.R. Martin, and R.L. Balster
Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298-0613, USA.

The lack of procedures which can unequivocally demonstrate cannabinoid self-administration in animals has been an obstacle to the study of the neural basis for the reinforcing effects of this drug class. Because delta(9)-tetrahydrocannabinol (delta(9)-THC) produce a relatively slow-onset, long-lasting behavioral effect, a self-administration procedure with widely spaced drug deliveries was evaluated as an alternative to fixed-ratio schedules which typically require frequent, closely spaced injections to demonstrate reinforcing effects. Three adult male rhesus monkeys were surgically implanted with intravenous catheters and trained to self-administer phencyclidine (PCP) under a 10min fixed-interval schedule of reinforcement. Three injections were available each day, separated by 2h periods during which responding had no programmed consequences. In an attempt to link the effect of the drug with the response which produced it, each 20s injection was paired with a red light which remained illuminated for 10min. PCP (100µg/kg/injection) maintained steady rates of responding during each availability period, ranging from approximately 0.2 to 0.7 responses/s. During 7 day substitution periods, Delta(9)-THC (17-100µg/kg/injection) maintained low rates of responding which occasionally surpassed those during vehicle substitutions, but fell far below rates maintained by PCP. Substitution tests with the potent Delta(9)-THC analog CP 55,940 also resulted in low rates of responding. These results demonstrate that Delta(9)-THC is a poor reinforcer in animals, even under conditions where some of its unfavourable biodispositional properties are taken into consideration.

UI MeSH Term Description Entries

Related Publications

R.S. Mansbach, and K.L. Nicholson, and B.R. Martin, and R.L. Balster
August 1992, The Journal of pharmacology and experimental therapeutics,
R.S. Mansbach, and K.L. Nicholson, and B.R. Martin, and R.L. Balster
April 2016, Behavioural pharmacology,
R.S. Mansbach, and K.L. Nicholson, and B.R. Martin, and R.L. Balster
December 1994, The Journal of pharmacology and experimental therapeutics,
R.S. Mansbach, and K.L. Nicholson, and B.R. Martin, and R.L. Balster
January 1980, Psychopharmacology,
R.S. Mansbach, and K.L. Nicholson, and B.R. Martin, and R.L. Balster
January 1978, Advances in the biosciences,
R.S. Mansbach, and K.L. Nicholson, and B.R. Martin, and R.L. Balster
April 1993, Neuropharmacology,
R.S. Mansbach, and K.L. Nicholson, and B.R. Martin, and R.L. Balster
December 2012, Behavioural pharmacology,
R.S. Mansbach, and K.L. Nicholson, and B.R. Martin, and R.L. Balster
February 1981, The Journal of pharmacology and experimental therapeutics,
R.S. Mansbach, and K.L. Nicholson, and B.R. Martin, and R.L. Balster
February 1980, Pharmacology, biochemistry, and behavior,
R.S. Mansbach, and K.L. Nicholson, and B.R. Martin, and R.L. Balster
June 1974, Psychopharmacologia,
Copied contents to your clipboard!